Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03775902Completed
Randomised, double-blind trial of nicorandil in insulin resistance (IR), sponsored by University of Copenhagen. Primary endpoint: Extracellular potassium concentration measured with microdialysis at 6 weeks. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03775902.